J&J Q1 earnings: ‘we feel very good about 2023’

Shares of Johnson & Johnson (NYSE: JNJ) opened down this morning after the consumer health and pharmaceutical company said it swung to a loss in its first financial quarter. What resulted in a loss this quarter? J&J faced a one-time $6.9 billion charge this quarter to settle lawsuits that accused is talc containing powders of […]